Sugi Predict

Sugi Predict / Compounds / SCHEMBL2216147

SCHEMBL2216147

SCHEMBL2216147

CC1(C)OB(c2ccnc(-c3ccccc3)c2)OC1(C)C

nearest known ligand 0.56

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ LIPG Q9Y5X9 10/20 0.56
▸ LPL P06858 9/20 0.56
▸ DGAT1 O75907 1/20 0.45
▸ ASIC3 Q9UHC3 1/20 0.45
▸ P4HB P07237 1/20 0.39
▸ PDGFRB P09619 1/20 0.39
▸ KDR P35968 1/20 0.39
▸ HTR1A P08908 1/20 0.38
▸ HTR7 P34969 1/20 0.38
▸ PIM1 P11309 1/20 0.38
▸ IDH1 O75874 1/20 0.37
▸ CYP2A6 P11509 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ CTDSP1 Q9GZU7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30866934 0.93 LIPG (0.55) LIPGLPLDGAT1ASIC3P4HB
SCHEMBL23347389 0.88 LPL (0.40) LIPGLPLDGAT1CYP2A6
SCHEMBL17714913 0.87 LIPG (0.49) LIPGLPLDGAT1ASIC3P4HB
SCHEMBL23487738 0.85 LIPG (0.67) LIPGLPLDGAT1ASIC3P4HB
SCHEMBL19933806 0.85 MAP4K4 (0.43) LIPGLPLDGAT1
SCHEMBL16403173 0.85 LPL (0.59) LIPGLPLDGAT1
SCHEMBL20598797 0.84 LIPG (0.53) LIPGLPLDGAT1ASIC3P4HB
SCHEMBL29940665 0.84 LIPG (0.53) LIPGLPLDGAT1ASIC3P4HB
SCHEMBL6224565 0.84 LPL (0.44) LIPGLPLPIM1
SCHEMBL19766317 0.83 LIPG (0.55) LIPGLPLDGAT1ASIC3P4HB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025215558-A1 COMPOUNDS FOR SPLICING MODULATION FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA (IT) 2025-10-16 — — WO disclosed
EP-4472956-A1 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE Bristol-Myers Squibb Company (US) 2024-12-11 — — EP disclosed
US-12162848-B2 Inhibitors of protein tyrosine phosphatase, compositions, and methods of use BRISTOL-MYERS SQUIBB COMPANY (US) 2024-12-10 — — US disclosed
US-12127470-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2024-10-22 — — US disclosed
US-11825734-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-11-21 — — US disclosed
US-11825734-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-11-21 — — US disclosed
US-11825734-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-11-21 — — US disclosed
EP-3313855-B1 METAL COMPLEX AND ORGANIC LIGHT-EMITTING DEVICE CAMBRIDGE DISPLAY TECH LTD (GB) 2023-10-25 — — EP disclosed
US-11788001-B2 Organic light emitting polymer comprising light-emitting repeat unit in backbone of polymer and device therewith SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2023-10-17 — — US disclosed
US-11788001-B2 Organic light emitting polymer comprising light-emitting repeat unit in backbone of polymer and device therewith SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2023-10-17 — — US disclosed
WO-2011109042-A1 PHOSPHORESCENT MATERIALS UNIVERSAL DISPLAY CORPORATION (US) 2011-09-09 — — WO disclosed
WO-2011109042-A1 PHOSPHORESCENT MATERIALS UNIVERSAL DISPLAY CORPORATION (US) 2011-09-09 — — WO disclosed
US-20110215710-A1 PHOSPHORESCENT MATERIALS UNIVERSAL DISPLAY CORPORATION (US) 2011-09-08 — — US disclosed
US-20110215710-A1 PHOSPHORESCENT MATERIALS UNIVERSAL DISPLAY CORPORATION (US) 2011-09-08 — — US disclosed
US-20110215710-A1 PHOSPHORESCENT MATERIALS UNIVERSAL DISPLAY CORPORATION (US) 2011-09-08 — — US disclosed
EP-2342305-A1 PHOSPHORESCENT MATERIALS Universal Display Corporation (US) 2011-07-13 — — EP disclosed
WO-2010027583-A1 PHOSPHORESCENT MATERIALS UNIVERSAL DISPLAY CORPORATION (US) 2010-03-11 — — WO disclosed
WO-2010028151-A1 PHOSPHORESCENT MATERIALS UNIVERSAL DISPLAY CORPORATION (US) 2010-03-11 — — WO disclosed
WO-2010028151-A1 PHOSPHORESCENT MATERIALS UNIVERSAL DISPLAY CORPORATION (US) 2010-03-11 — — WO disclosed
WO-2010027583-A1 PHOSPHORESCENT MATERIALS UNIVERSAL DISPLAY CORPORATION (US) 2010-03-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11825734-B2 Organic electroluminescent materials and devices OCIAD2, OCIAD1, OSBP LIPG 228/4885LPL 91/4885DGAT1 89/4885
US-12127470-B2 Organic electroluminescent materials and devices SOD1, CLTB, L1CAM LIPG 3545/4885LPL 3973/4885DGAT1 4690/4885
US-12162848-B2 Inhibitors of protein tyrosine phosphatase, compositions, and methods of use PTPN2, PTPN22, PTPN5 LIPG 163/4885LPL 141/4885DGAT1 1007/4885
US-20110215710-A1 PHOSPHORESCENT MATERIALS NUDC, P2RY4, P2RY6 LIPG 4241/4885LPL 4330/4885DGAT1 4566/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.